Image

Registry of X-linked Adrenoleukodystrophy

Registry of X-linked Adrenoleukodystrophy

Recruiting
6-70 years
All
Phase N/A

Powered by AI

Overview

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

Description

In this study, X-ALD patients will be selected as study participants. Through a longitudinal collection of genetic, imaging and clinical symptoms data of the patients and carriers. The purpose of this study is to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients. Through the long-term follow-up of imaging and clinical symptoms progress and outcome of X-ALD patients, combined with genetic data, we will improve the relationships between genes and phenotypes, and explore the deep insight in the pathophysiological mechanism of X-ALD, to provide a theoretical basis for the treatment and management of X-ALD patients.

Eligibility

Inclusion Criteria:

X-ALD group:

  • Meet the diagnostic criteria of X-ALD and supported by the results of genetic and very long chain fatty acid (VLCFA) test;
  • Age: 6 - 70 years old;
  • Able to communicate normally, and complete the test of scale as instructed (confirmed by the field test of scale);
  • Sign the informed consent.

Carrier-control group:

        Healthy people who have no significant difference in age, sex and education comparing with
        the X-ALD group, volunteer to participate in this study, could complete the test of scale
        as instructed, and meet the following criteria:
          -  Eligible for asymptomatic carriers in genetic tests (preference of patient's mother
             and close relatives);
          -  Age: 6 - 70 years old, able to complete the test of scale as instructed (confirmed by
             the field test of scale);
          -  No history of psychiatric diseases.
        Exclusion Criteria:
          -  Other hereditary diseases;
          -  Other severe central nervous diseases;
          -  History of surgery of brain or eye;
          -  Psychiatric and psychological diseases, such as anxiety and depression;
          -  Metal foreign body or prosthesis in the human body (such as pacemaker and insulin
             pump), claustrophobia, and other MRI contraindications;
          -  History of surgery associated with gastrointestinal tract;
          -  No informed consent;
          -  Unable to tolerate MRI or eye related tests.

Study details
    X-linked Adrenoleukodystrophy

NCT05939232

Beijing Tiantan Hospital

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.